Becton, Dickinson and Co. | BDX - Stammkapital

Aktienkurs
152.13
Täglich Wechseln
-2.72 -1.76%
Monatlich
-3.88%
Jährlich
-25.82%
Q2 Prognose
155.05




Stammkapital Veränderung Datum
Abbott USD 1.74B 23.39B 2025-09
Agilent USD 282.7M 358K 2025-12
Align Technology USD 71.75M 736K 2025-12
AngioDynamics USD 41.57M 127K 2025-09
Avanos Medical USD 46.46M 39.46K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Bio-Rad Laboratories USD 26.97M 90K 2025-09
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.1M 3.71M 2025-12
Danaher USD 707.7M 800K 2026-03
Dentsply International USD 199.5M 196.5M 2025-09
Dexcom USD 384.8M 5.2M 2025-12
Edwards Lifesciences USD 580.7M 0 2025-12
Globus Medical USD 135.06M 449K 2025-12
Insulet USD 70.35M 1000 2025-12
Integra LifeSciences USD 77.89M 34K 2025-12
Intuitive Surgical USD 355.17M 674K 2026-03
J&J USD 2.41B 1.74M 2025-12
Masimo USD 52.1M 1000K 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Solventum Corp USD 173.49M 51.34K 2025-12
Stryker USD 382.4M 93K 2025-12
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.19M 1000 2025-12
Terumo JPY 1.48B 0 2025-12
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Zimmer Biomet Holdings USD 198.18M 18.44K 2025-12